Nxt-ID Inc. (NASDAQ: NXTD) shares are -7.11% down in the year-to-date (YTD) period and have moved -0.02% or $0.0 lower in the latest trading session. However, stock’s trailing 12-month performance remains nearly +96.29% lower. Comparatively, the stock is -52.97% down YTD and 7.79% over the trailing 3-month period. If we look at the shorter duration, its week performance is -3.80% and -8.55% over the month.
Gold bugs are shouting from the rooftops in excitement, but that doesn’t mean you rush out and just buy any gold stock…That’s why we laid out The 2021 Ultimate Gold Portfolio – to dissect the treasure from the trash.
On April 20, 2017, Maxim Group recommended the NXTD stock is a Buy, while earlier, Maxim Group had Reiterated the stock as a Buy on November 20, 2017. 1 analysts offering the recommendations for the stock have a consensus rating of 3.00 to suggest that the NXTD stock is a “Hold. 0 of the 1 analysts rate the stock as a “Sell”, while 0 has rated it as “Underweight”. 0 recommend buying, with 0 rating it as an Overweight.
The stock currently trades at $0.42. The forecasts give the Nxt-ID Inc. stock a price target range of $0.35 on the higher side while at least one analyst think the stock could plunge to a low of $0.35. The two limits represent an downside potential of -20.0% or -20.0%.
Insider Transactions Summary
According to SEC data, total insider shares purchases at the company stands at 6 over the last 12 months, while SEC filings reveal that there have been 0 insider sales over the same period. Insiders have purchases 246,540 shares while those sold by company executives and officers stand at 0. The last 3 months have seen insiders trade a total of 0 and 0 in purchases and sales respectively.
BIO-key International Inc. (NASDAQ:BKYI), on the other hand, is trading around $0.61 with a market cap of $35.38M and analyst research firms have a positive stance on its shares. Some analysts are even forecasting -$0.15 per share in earnings this year on a short term (1 year) basis.
Let us briefly look at the BIO-key International Inc. (BKYI) financials, with a focus on its operating details as indicated in its earnings report for the last quarter.
Company balance sheet and cash flow
BKYI’s operating expenses over the recent quarter were at $1.68 million. This represented a -446.91% of the company’s total revenues which amounted $0.31 million. With this in place, we can see that the company’s diluted EPS declined -$0.08 on the year-over-year period, shrinking to -$0.10 as given in the last earnings report.
In terms of the balance sheet & cash flow as of (Sep 2020), the total assets figure advanced to $5.75 million from $3.02 million over the previous quarter. Short term investments amounted to $0.52 million while total current assets were at $2.29 million. The cash flow from operating activities totaled -$1.97 million, significantly lower than the -$0.26 million reported in the year-ago quarter. The company’s free cash flow for the quarter was -$1.97 million.
Insiders have transacted a total of 30 times at BIO-key International Inc. over the last 6 months, with insider purchases undertaken 30 times and accounting for 37,468 shares. Insider sales totaled 0 shares over the same period, with these deals completed in 0 transactions. Looking at these numbers, we realize that net purchases over that period are 30.0 shares. Insiders now hold a total of 35.15M shares after the latest sales, with 0.40% net shares purchased.
Insiders own 0.20% of the company shares, while shares held by institutions stand at 0.50% with a share float percentage of 52.68M. Investors are also buoyed by the number of investors in a company, with BIO-key International Inc. having a total of 6 institutions that hold shares in the company.